Recursion Pharmaceuticals, Inc.: director Blake Borgeson sold 50,000 shares

What happened

• Blake Borgeson, a director, sold 50,000 shares in an open market or private sale at a weighted average price of $4.84 for total proceeds of $242,000.

Key details

• Transaction date: Oct 06, 2026. Transaction code: S (sale).
• Price details: executed in multiple trades at prices ranging from $4.80 to $5.00; weighted average sale price $4.84.
• Shares owned following the transaction: not reported in this filing.
• Footnotes: F1 — transaction pursuant to a Rule 10b5-1 trading plan adopted Aug 31, 2025. F2 — sale executed in multiple trades; reporting person will provide the number of shares sold at each price upon request by the SEC, the issuer, or a security holder.
• Form 4 filed on Oct 07, 2026 (one day after the transaction).

Why it may matter

• The filing reports a market/private sale executed under a Rule 10b5-1 plan.
• A filing does not show why the insider traded or why the company acted.